2. As of noon trading, Baxter International ( BAX) is down $0.74 (-1.0%) to $71.50 on average volume. Thus far, 1.0 million shares of Baxter International exchanged hands as compared to its average daily volume of 2.7 million shares. The stock has ranged in price between $71.45-$72.30 after having opened the day at $72.24 as compared to the previous trading day's close of $72.24. Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. Baxter International has a market cap of $38.8 billion and is part of the health care sector. Shares are up 7.2% year to date as of the close of trading on Wednesday. Currently there are 12 analysts that rate Baxter International a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates Baxter International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, expanding profit margins, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Baxter International Ratings Report now. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.